CV Sciences (CVSI) Cash & Equivalents Growth (3y) (2013 - 2026)
CV Sciences (CVSI) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | 21.81% |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 11.05% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -4.92% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 7.80% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 19.10% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 12.11% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 27.55% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 13.03% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 32.82% |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -46.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46.01% |
| Mar 31, 2026 | -24.36% |
| Dec 31, 2025 | -23.09% |
| Sep 30, 2025 | -30.58% |
| Jun 30, 2025 | -7.35% |
| Mar 31, 2025 | -30.69% |
| Dec 31, 2024 | -30.88% |
| Jun 30, 2024 | -42.12% |
| Mar 31, 2024 | -49.58% |
| Dec 31, 2023 | -31.09% |
| Dec 31, 2022 | -46.54% |
| Dec 31, 2021 | 66.11% |
| Jun 30, 2021 | -27.49% |
| Dec 31, 2020 | 72.86% |
| Dec 31, 2019 | 55.81% |
| Dec 31, 2018 | -16.67% |
| Jun 30, 2018 | 52.72% |
| Dec 31, 2017 | -30.32% |
| Sep 30, 2017 | -39.91% |
| Dec 31, 2016 | -22.18% |